A real world treatment study of osimertinib: ASTRIS study Korean subgroup analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, BC[Cho, B. C.] | - |
dc.contributor.author | Kim, DW[Kim, D-W.] | - |
dc.contributor.author | Park, K[Park, K.] | - |
dc.contributor.author | Lee, JS[Lee, J-S.] | - |
dc.contributor.author | Yoo, SS[Yoo, S. S.] | - |
dc.contributor.author | Kang, JH[Kang, J. H.] | - |
dc.contributor.author | Lee, SY[Lee, S. Y.] | - |
dc.contributor.author | Kim, CH[Kim, C. H.] | - |
dc.contributor.author | Jang, SH[Jang, S. H.] | - |
dc.contributor.author | Kim, YC[Kim, Y-C.] | - |
dc.contributor.author | Yoon, HK[Yoon, H-K.] | - |
dc.contributor.author | Kim, SW[Kim, S-W.] | - |
dc.date.accessioned | 2021-07-30T04:45:29Z | - |
dc.date.available | 2021-07-30T04:45:29Z | - |
dc.date.created | 2018-04-10 | - |
dc.date.issued | 2017-11 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/26552 | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.title | A real world treatment study of osimertinib: ASTRIS study Korean subgroup analysis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, K[Park, K.] | - |
dc.identifier.wosid | 000425626900403 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, v.28 | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.citation.title | ANNALS OF ONCOLOGY | - |
dc.citation.volume | 28 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu
COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.